Results from the European Prospective Investigation into Cancer and Nutrition Link Vitamin B6 Catabolism and Lung Cancer Risk.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Zuo, HuiUeland, Per M
Midttun, Øivind
Vollset, Stein E
Tell, Grethe S
Theofylaktopoulou, Despoina
Travis, Ruth C
Boutron-Ruault, Marie-Christine
Fournier, Agnès
Severi, Gianluca
Kvaskoff, Marina
Boeing, Heiner
Bergmann, Manuela M
Fortner, Renée T
Kaaks, Rudolf
Trichopoulou, Antonia
Kotanidou, Anastasia
Lagiou, Pagona
Palli, Domenico
Sieri, Sabina
Panico, Salvatore
Bueno-de-Mesquita, H Bas
Peeters, Petra H
Grankvist, Kjell
Johansson, Mikael
Agudo, Antonio
Garcia, Jose Ramon Quiros
Larranaga, Nerea
Sanchez, Maria-Jose
Chirlaque, Maria Dolores
Ardanaz, Eva
Chuang, Shu-Chun
Gallo, Valentina
Brennan, Paul
Johansson, Mattias
Ulvik, Arve
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Results from the European Prospective Investigation into Cancer and Nutrition Link Vitamin B6 Catabolism and Lung Cancer Risk.Published in
Cancer Res 2018; 78(1):302-8Publiekssamenvatting
Circulating pyridoxal-5'-phosphate (PLP) has been linked to lung cancer risk. The PAr index, defined as the ratio 4-pyridoxic acid/(pyridoxal + PLP), reflects increased vitamin B6 catabolism during inflammation. PAr has been defined as a marker of lung cancer risk in a prospective cohort study, but analysis of a larger numbers of cases are needed to deepen the significance of this study. Here, we conducted a nested case-control study within the European Prospective Investigation into Cancer and Nutrition (EPIC, n = 521,330), which included 892 incident lung cancer cases and 1,748 controls matched by center, gender, date of blood collection, and date of birth. The association of PAr with risk of lung cancer was evaluated by using conditional logistic regression. Study participants with elevated PAr experienced higher risk of lung cancer in a dose-response fashion, with a doubling in PAr levels associated with 52% higher odds of lung cancer after adjustment for tobacco smoking, serum cotinine levels, educational attainment, and BMI [OR, 1.52; 95% confidence interval (CI) 1.27-1.81; P < 0.001]. Additional adjustment for intake of vegetables and fruits and physical activity did not materially affect risk association. The association of PAr with lung cancer risk was similar in both genders but slightly stronger in former smokers and in participants diagnosed with squamous cell carcinoma. This study provides robust evidence that increased vitamin B6 catabolism is independently associated with a higher risk of future lung cancer.Significance: This large cohort study firmly establishes an association between an index of vitamin B6 levels with lung cancer risk. Cancer Res; 78(1); 302-8. ©2017 AACR.PMID
29070616ae974a485f413a2113503eed53cd6c53
10.1158/0008-5472.CAN-17-1923
Scopus Count
Collections
Related articles
- Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3).
- Authors: Zuo H, Ueland PM, Midttun Ø, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, Johansson M, Hultdin J, Grankvist K, Stevens VL, McCullough ML, Weinstein SJ, Albanes D, Ziegler RG, Freedman ND, Caporaso NE, Langhammer A, Hveem K, Næss M, Buring JE, Lee I, Gaziano JM, Severi G, Zhang X, Stampfer MJ, Han J, Zeleniuch-Jacquotte A, Marchand LL, Yuan J, Wang R, Koh W, Gao Y, Ericson U, Visvanathan K, Jones MR, Relton C, Brennan P, Johansson M, Ulvik A
- Issue date: 2019 Mar 1
- Serum B(6) vitamers (pyridoxal 5'-phosphate, pyridoxal, and 4-pyridoxic acid) and pancreatic cancer risk: two nested case-control studies in Asian populations.
- Authors: Huang JY, Butler LM, Midttun Ø, Koh WP, Ueland PM, Wang R, Jin A, Gao YT, Yuan JM
- Issue date: 2016 Dec
- Markers of vitamin B6 status and metabolism as predictors of incident cancer: the Hordaland Health Study.
- Authors: Zuo H, Ueland PM, Eussen SJ, Tell GS, Vollset SE, Nygård O, Midttun Ø, Meyer K, Ulvik A
- Issue date: 2015 Jun 15
- A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
- Authors: Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, Johansson M, Scelo G, Ulvik A, Midttun Ø, Ueland PM, Dahm CC, Halkjær J, Olsen A, Johnson T, Katzke V, Schulze MB, Masala G, Segrado F, de Magistris MS, Sacerdote C, Ocké MC, Luján-Barroso L, Ching-López A, Huerta JM, Ardanaz E, Amiano P, Ericson U, Manjer J, Gylling B, Johansson I, Schmidt J, Weiderpass E, Riboli E, Cross AJ, Muller DC
- Issue date: 2021 Jul 1
- Association of Serum Pyridoxal-5'-Phosphate, Pyridoxal, and PAr with Colorectal Cancer Risk: A Large-Scale Case-Control Study.
- Authors: Xu L, Fang YJ, Che MM, Abulimiti A, Huang CY, Zhang CX
- Issue date: 2022 Jun 9